More on CORT
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $88.48 |
|
|||
| Open | $90.30 | ||||
| 52 Wk High | $10.00 | ||||
| 52 Wk Low | $3.22 | ||||
| Day High | $90.30 | ||||
| Day Low | $86.82 | ||||
| P/E | N/A | ||||
| EPS | $-0.46 | ||||
| Volume | 772,002 | ||||
- Form 4 CORCEPT THERAPEUTICS For: Jun 16 Filed by: WILSON JAMES N
- Form 4 CORCEPT THERAPEUTICS For: Jun 17 Filed by: MAHONEY DAVID L
- Form 8-K CORCEPT THERAPEUTICS For: Jun 17
- Form 4 CORCEPT THERAPEUTICS For: Jun 15 Filed by: Mokari Atabak
- Corcept resubmits NDA for relacorilant to treat Cushing's syndrome
- Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome
- Form 144 CORCEPT THERAPEUTICS Filed by: MAHONEY DAVID L
- Form 144 CORCEPT THERAPEUTICS Filed by: WILSON JAMES N
- Corcept reports improved diabetes outcomes with Korlym and GLP-1 combo
- Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym®
Entities mentioned with CORT
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
